Park Medi World's initial public offering (IPO) is entering its final day, with the issue priced at Rs 154-162 per share. The company aims to raise Rs 920 crore through this book-built issue, which will be listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE).
As of the second day, the IPO has been subscribed 98%, with retail individual investors (RIIs) and non-institutional investors (NIIs) showing strong interest. However, qualified institutional buyers (QIBs) have been more reserved, bidding for only 32% of the shares allocated to them.
The grey market premium (GMP) for Park Medi World's IPO is currently trading at a premium of Rs 8.5, around 5.3% above the issue price. This indicates a mild decline in grey market interest, with the stock expected to list in the range of Rs 170-171.
Park Medi World is one of North India's largest hospital networks, operating 14 NABH-accredited multi-super-speciality hospitals across Haryana, Delhi, Punjab, and Rajasthan. The company has 3,000 beds and employs over 1,000 doctors and 2,100 nurses, offering 30+ specialities.
In FY25, Park Medi World posted revenue of Rs 1,393.6 crore, up from Rs 1,231.1 crore in FY24. The company's consolidated profit after tax (PAT) rose from Rs 152 crore to Rs 213.2 crore during the same period. In H1 FY26, revenue reached Rs 808.7 crore, with a PAT of Rs 139.1 crore and EBITDA of Rs 217.2 crore.
Broking firms such as Anand Rathi Research and MasterTrust Broking have given the IPO a "Subscribe – Long Term" rating, citing the company's strong positioning to benefit from rising demand for affordable, quality healthcare. The IPO is expected to be a promising long-term investment, driven by government initiatives and an ageing population.
Download the TradeKaizen app to practice F&O trading with real-time market data anytime, anywhere.
Get it on Google PlayConnect with fellow traders, share strategies, and improve your trading skills in our Telegram group.
Join Telegram